SCHEMBL6763707

SCHEMBL6763707

CCOc1ccc(C(c2ccc(OCC(=O)O)cc2)N(C=O)OCC2c3ccccc3-c3ccccc32)c(OCC)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 3/20 0.38
▸ MAPT P10636 1/20 0.38
▸ GLA P06280 1/20 0.35
▸ ALDH1A1 P00352 2/20 0.35
▸ TSHR P16473 1/20 0.35
▸ PPARG P37231 2/20 0.35
▸ PPARA Q07869 2/20 0.35
▸ KDM4E B2RXH2 2/20 0.35
▸ PRNP P04156 1/20 0.35
▸ HPGD P15428 1/20 0.35
▸ PPARD Q03181 2/20 0.34
▸ FFAR1 O14842 1/20 0.34
▸ POLB P06746 1/20 0.34
▸ TDP1 Q9NUW8 1/20 0.34
▸ LTB4R Q15722 1/20 0.33
▸ LTB4R2 Q9NPC1 1/20 0.33
▸ PLA2G4B P0C869 1/20 0.33
▸ PTGIR P43119 1/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ CYP1A2 P05177 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1000960 0.90 THRA (0.41) GLAALDH1A1TSHRKDM4EHPGD
SCHEMBL3367291 0.90 THRA (0.41) GLAALDH1A1TSHRKDM4EHPGD
SCHEMBL6343747 0.80 PTGS1 (0.36) L3MBTL1MAPTALDH1A1TSHRPPARD
SCHEMBL1623875 0.80 PTGS1 (0.36) L3MBTL1MAPTALDH1A1TSHRPPARD
SCHEMBL6763712 0.78 L3MBTL1 (0.40) L3MBTL1MAPTGLAALDH1A1TSHR
SCHEMBL7314603 0.78 PPARG (0.38) L3MBTL1TSHRPPARGPPARATDP1
SCHEMBL3785947 0.69 NPC1 (0.44) ALDH1A1TSHRHPGDPOLBMEN1
SCHEMBL6567974 0.69 FABP5 (0.37) L3MBTL1MAPTTSHRPPARGPPARA
SCHEMBL2131722 0.69 THRA (0.43) L3MBTL1ALDH1A1TSHRHPGDFFAR1
SCHEMBL3367289 0.68 KMT2A (0.45) MAPTALDH1A1HPGDMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040242854-A1 Chemical capture reagent GE HEALTHCARE UK LIMITED (GB) 2004-12-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040242854-A1 Chemical capture reagent SPPL2B, PRXL2A, PLG L3MBTL1 3390/4885MAPT 3605/4885GLA 509/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback